Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases

Hiroyuki Murota, Shun Kitaba, Mamori Tani, Mari Wataya-Kaneda, Hiroaki Azukizawa, Atsushi Tanemura, Noriko Umegaki, Mika Terao, Yorihisa Kotobuki, Ichiro Katayama

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Background: The impairment that pruritic skin diseases have on patient productivity at work, in the classroom, and in daily activities is substantial and needs to be characterized. The objective of this study was to determine how pruritic skin diseases impact patient productivity and quality of life (QOL), in order to improve the measurement of these endpoints to allow the influence of treatment options including sedative and nonsedative antihistamines to be analyzed. Methods: The impact of pruritic skin diseases and the effect of antihistamine therapy on work, classroom, and daily productivity were evaluated using the Work Productivity Assessment Index-Allergy Specific Questionnaire. The intensity of itch and patient QOL were assessed using a visual analogue scale and Skindex-16, respectively. Results: Pruritic skin diseases resulted in significant impairment of work, classroom, and daily productivity. The severity of overall work impairment in atopic dermatitis (AD), urticaria, and prurigo was higher than for other diseases analyzed. However, classroom activity was more adversely affected in patients with urticaria relative to other diseases. All pruritic diseases in this study negatively impacted daily activity to a similar degree. Impaired productivity was significantly improved in patients taking non-sedative antihistamines for 1 month, and the improvements correlated with the alleviation of itch and improved QOL. Conclusions: These results indicate that pruritic skin diseases reduce patient productivity at work, in the classroom, and during daily activities, and that non-sedative antihistamines may offer an advantage over sedative antihistamines for alleviating certain negative consequences of these skin diseases.

Original languageEnglish
Pages (from-to)345-354
Number of pages10
JournalAllergology International
Volume59
Issue number4
DOIs
Publication statusPublished - 2010
Externally publishedYes

Fingerprint

Histamine Antagonists
Hypnotics and Sedatives
Skin Diseases
Quality of Life
Urticaria
Prurigo
Atopic Dermatitis
Visual Analog Scale
Hypersensitivity
Therapeutics

Keywords

  • Antihistamine
  • Productivity
  • Pruritic
  • Quality-of-life
  • Skin diseases
  • WPAI-AS

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. / Murota, Hiroyuki; Kitaba, Shun; Tani, Mamori; Wataya-Kaneda, Mari; Azukizawa, Hiroaki; Tanemura, Atsushi; Umegaki, Noriko; Terao, Mika; Kotobuki, Yorihisa; Katayama, Ichiro.

In: Allergology International, Vol. 59, No. 4, 2010, p. 345-354.

Research output: Contribution to journalArticle

Murota, H, Kitaba, S, Tani, M, Wataya-Kaneda, M, Azukizawa, H, Tanemura, A, Umegaki, N, Terao, M, Kotobuki, Y & Katayama, I 2010, 'Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases', Allergology International, vol. 59, no. 4, pp. 345-354. https://doi.org/10.2332/allergolint.10-OA-0182
Murota, Hiroyuki ; Kitaba, Shun ; Tani, Mamori ; Wataya-Kaneda, Mari ; Azukizawa, Hiroaki ; Tanemura, Atsushi ; Umegaki, Noriko ; Terao, Mika ; Kotobuki, Yorihisa ; Katayama, Ichiro. / Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. In: Allergology International. 2010 ; Vol. 59, No. 4. pp. 345-354.
@article{1814371b73614d248f08b489bd787509,
title = "Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases",
abstract = "Background: The impairment that pruritic skin diseases have on patient productivity at work, in the classroom, and in daily activities is substantial and needs to be characterized. The objective of this study was to determine how pruritic skin diseases impact patient productivity and quality of life (QOL), in order to improve the measurement of these endpoints to allow the influence of treatment options including sedative and nonsedative antihistamines to be analyzed. Methods: The impact of pruritic skin diseases and the effect of antihistamine therapy on work, classroom, and daily productivity were evaluated using the Work Productivity Assessment Index-Allergy Specific Questionnaire. The intensity of itch and patient QOL were assessed using a visual analogue scale and Skindex-16, respectively. Results: Pruritic skin diseases resulted in significant impairment of work, classroom, and daily productivity. The severity of overall work impairment in atopic dermatitis (AD), urticaria, and prurigo was higher than for other diseases analyzed. However, classroom activity was more adversely affected in patients with urticaria relative to other diseases. All pruritic diseases in this study negatively impacted daily activity to a similar degree. Impaired productivity was significantly improved in patients taking non-sedative antihistamines for 1 month, and the improvements correlated with the alleviation of itch and improved QOL. Conclusions: These results indicate that pruritic skin diseases reduce patient productivity at work, in the classroom, and during daily activities, and that non-sedative antihistamines may offer an advantage over sedative antihistamines for alleviating certain negative consequences of these skin diseases.",
keywords = "Antihistamine, Productivity, Pruritic, Quality-of-life, Skin diseases, WPAI-AS",
author = "Hiroyuki Murota and Shun Kitaba and Mamori Tani and Mari Wataya-Kaneda and Hiroaki Azukizawa and Atsushi Tanemura and Noriko Umegaki and Mika Terao and Yorihisa Kotobuki and Ichiro Katayama",
year = "2010",
doi = "10.2332/allergolint.10-OA-0182",
language = "English",
volume = "59",
pages = "345--354",
journal = "Allergology International",
issn = "1323-8930",
publisher = "Japanese Society of Allergology",
number = "4",

}

TY - JOUR

T1 - Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases

AU - Murota, Hiroyuki

AU - Kitaba, Shun

AU - Tani, Mamori

AU - Wataya-Kaneda, Mari

AU - Azukizawa, Hiroaki

AU - Tanemura, Atsushi

AU - Umegaki, Noriko

AU - Terao, Mika

AU - Kotobuki, Yorihisa

AU - Katayama, Ichiro

PY - 2010

Y1 - 2010

N2 - Background: The impairment that pruritic skin diseases have on patient productivity at work, in the classroom, and in daily activities is substantial and needs to be characterized. The objective of this study was to determine how pruritic skin diseases impact patient productivity and quality of life (QOL), in order to improve the measurement of these endpoints to allow the influence of treatment options including sedative and nonsedative antihistamines to be analyzed. Methods: The impact of pruritic skin diseases and the effect of antihistamine therapy on work, classroom, and daily productivity were evaluated using the Work Productivity Assessment Index-Allergy Specific Questionnaire. The intensity of itch and patient QOL were assessed using a visual analogue scale and Skindex-16, respectively. Results: Pruritic skin diseases resulted in significant impairment of work, classroom, and daily productivity. The severity of overall work impairment in atopic dermatitis (AD), urticaria, and prurigo was higher than for other diseases analyzed. However, classroom activity was more adversely affected in patients with urticaria relative to other diseases. All pruritic diseases in this study negatively impacted daily activity to a similar degree. Impaired productivity was significantly improved in patients taking non-sedative antihistamines for 1 month, and the improvements correlated with the alleviation of itch and improved QOL. Conclusions: These results indicate that pruritic skin diseases reduce patient productivity at work, in the classroom, and during daily activities, and that non-sedative antihistamines may offer an advantage over sedative antihistamines for alleviating certain negative consequences of these skin diseases.

AB - Background: The impairment that pruritic skin diseases have on patient productivity at work, in the classroom, and in daily activities is substantial and needs to be characterized. The objective of this study was to determine how pruritic skin diseases impact patient productivity and quality of life (QOL), in order to improve the measurement of these endpoints to allow the influence of treatment options including sedative and nonsedative antihistamines to be analyzed. Methods: The impact of pruritic skin diseases and the effect of antihistamine therapy on work, classroom, and daily productivity were evaluated using the Work Productivity Assessment Index-Allergy Specific Questionnaire. The intensity of itch and patient QOL were assessed using a visual analogue scale and Skindex-16, respectively. Results: Pruritic skin diseases resulted in significant impairment of work, classroom, and daily productivity. The severity of overall work impairment in atopic dermatitis (AD), urticaria, and prurigo was higher than for other diseases analyzed. However, classroom activity was more adversely affected in patients with urticaria relative to other diseases. All pruritic diseases in this study negatively impacted daily activity to a similar degree. Impaired productivity was significantly improved in patients taking non-sedative antihistamines for 1 month, and the improvements correlated with the alleviation of itch and improved QOL. Conclusions: These results indicate that pruritic skin diseases reduce patient productivity at work, in the classroom, and during daily activities, and that non-sedative antihistamines may offer an advantage over sedative antihistamines for alleviating certain negative consequences of these skin diseases.

KW - Antihistamine

KW - Productivity

KW - Pruritic

KW - Quality-of-life

KW - Skin diseases

KW - WPAI-AS

UR - http://www.scopus.com/inward/record.url?scp=78650942660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650942660&partnerID=8YFLogxK

U2 - 10.2332/allergolint.10-OA-0182

DO - 10.2332/allergolint.10-OA-0182

M3 - Article

VL - 59

SP - 345

EP - 354

JO - Allergology International

JF - Allergology International

SN - 1323-8930

IS - 4

ER -